Brief: Grand Pharmaceutical Says Clinical Trial Application For Tlx591-Cdx Approved
17/10/2022 11:38
Oct 17 (Reuters) - Grand Pharmaceutical 0512.HK :
* CLINICAL TRIAL APPLICATION FOR TLX591-CDX APPROVED BY
NATIONAL
MEDICAL PRODUCTS ADMINISTRATION OF PRC
Further company coverage: 0512.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement